Clinical Trial Update: Atrial Fibrillation Progression Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating progression in atrial fibrillation sponsored by Biosense Webster was terminated, with results posted on 2020-05-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED | Results posted: 2020-05-14